Frank Kalkbrenner
Frank studied medicine and holds a degree in Pharmacology and Toxicology. He spent more than 10 years in academic research in the Max-Planck
Frank studied medicine and holds a degree in Pharmacology and Toxicology. He spent more than 10 years in academic research in the Max-Planck-Institute for Molecular Genetics in Berlin and in the Institute of Pharmacology of the Freie Universität, Berlin. His academic research focused on gene regulation and signal transduction mediated by ion channels and G proteins. In 1997 he began his industrial career by joining Schering AG as senior scientist in Experimental Dermatology. In 1999 Frank joined Boehringer Ingelheim and held several positions in the department of Pulmonary Research. In 2005 he took over the responsibility for the Licensing Department. In this function, he was responsible for the licensing activities of the German Boehringer Ingelheim organization as well as for competitive assessment and scientific information systems. In addition, he built up the NBE Research unit at the German Research site in Biberach. In 2010 - shortly after its start - Frank joint the Boehringer Ingelheim Venture Fund.